MedTrace Logo

Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients

NCT03149874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2023-02-08

No results posted yet for this study

Summary

The aim of this study is to examine the result of seroprotection using the accelerated vaccination schedule in vaccination of hemodialysis patient through using combined hepatitis A and B vaccine.

Conditions

Interventions

DRUG

Hepatitis B recombinant DNA vaccine

Hepatitis B recombinant DNA vaccine

DRUG

Combined hepatitis A and B vaccine

Combined hepatitis A and B vaccine given to the patients

Sponsors & Collaborators

  • New Jeddah Clinic Hospital

    collaborator INDUSTRY

  • Benha University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2017-04-30
Completion
2017-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03149874 on ClinicalTrials.gov